Clinical Research Corner
Volunteers Needed for Testing Malaria Prevention Drug
Malaria is spread by mosquitoes in tropical areas. Mosquitoes can carry parasites that cause the disease. People who are infected with malaria may become sick with high fever, chills, and flu-like illness. If not treated right away, malaria can become deadly.
Preventing malaria could help save hundreds of thousands of lives each year. But there are no vaccines to prevent infection. NIH's Vaccine Research Center is testing an experimental product to determine if it can prevent malaria infection. The NIH team is looking for healthy volunteers to take part in the study.
Some volunteers will be given the experimental product by needle injection or by IV infusion. Others will be in a control group. Afterwards, all volunteers will be bitten by mosquitoes that carry malaria. Everyone will be treated with an FDA-approved medication to make sure that everyone is cured of malaria.
The study will test to see if the product is safe and how your body responds to it. The study involves several visits and blood draws. Volunteers will be compensated for their time.
NIH Office of Communications and Public Liaison
Building 31, Room 5B52
Bethesda, MD 20892-2094
Editor: Harrison Wein, Ph.D.
Managing Editor: Tianna Hicklin, Ph.D.
Illustrator: Alan Defibaugh
Attention Editors: Reprint our articles and illustrations in your own publication. Our material is not copyrighted. Please acknowledge NIH News in Health as the source and send us a copy.
For more consumer health news and information, visit health.nih.gov.
For wellness toolkits, visit www.nih.gov/wellnesstoolkits.